DIVIDEND ANNOUNCEMENT: Becton, Dickinson & Co (NYSE:BDX) on 01/27/2026 declared a dividend of $1.0500 per share

Becton, Dickinson & Co (NYSE:BDX) on 01/27/2026 declared a dividend of $ 1.0500 per share payable on March 31, 2026 to shareholders of record as of March 10, 2026.

Becton, Dickinson & Co (NYSE:BDX) has paid dividends since 1926, has a current dividend yield of 2.0646936893% and has increased its dividends for 14 successive years.

Becton, Dickinson & Co's market cap is $ 58,059,932,980 and has a PE ratio of 34.95. The stock price closed yesterday at $ 203.42 and has a 52 week low/high of $ 162.29 and $ 251.99.

Becton, Dickinson and Co. is a global medical technology company. Co. is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring solutions and pharmaceutical systems.

For more information on Becton, Dickinson & Co click here.